You have to be signed in to use this resource.
S02 E90 - Episode 90: Piperacillin-Tazobactam, automated systems, and CLSI breakpoints
This episodes features a conversation with Dr. Romney Humphries and Dr. April Abbott. They join the podcast to talk about a study where Piperacillin-Tazobactam (TZP) was evaluated. Testing results from automated systems were compared to a reference method. How did the systems perform? What are the challenges? What are CLSI breakpoints and FDA breakpoints? What is the MERINO trial? Tune in to find out.
Resource details
| Contributed by: | Pathology Portal |
| Authored by: |
|
| Licence: | © All rights reserved More information on licences |
| First contributed: | 19 May 2023 |
| Audience access level: | Full user |
Share this resource
Report an issue with this resource
You may report a resource, for example, if there is an issue with copyright infringement, breach of personal data, factual inaccuracies, typing errors or safety concerns. The type of issue will determine whether the resource is immediately removed from the platform or if the contributor is asked to make amendments. You can report a resource from the resource information page or by contacting the Learning Hub support team.
You can contact the Learning Hub support team by completing the support form or if you have a general enquiry you can email enquiries@learninghub.nhs.uk.